Section 4: Clinical Pharmacy Services 2022
DOI: 10.1136/ejhpharm-2022-eahp.70
|View full text |Cite
|
Sign up to set email alerts
|

4CPS-019 Reactogenicity of the BNT162b2 (Pfizer-BioNTech) mRNA vaccine against COVID-19 in tertiary hospital workers

Abstract: Conclusion and relevance Almost half of citizens and physicians currently disagree with vaccination in pharmacies in the Czech Republic. The physicians' main concern is the inability of pharmacists to deal with adverse drug reactions. For citizens, the major disadvantage is locating PBV in a pharmacy.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles